Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading

Journal of Heart and Lung Transplantation

Volumn 24, Issue 4, 2005, Pages 454-461

  Bick, Roger J ^a,b   Bagwell, Shannon H ^a   Jones, Chad E ^a   Poindexter, Brian J ^a   Buja, L Maximilian ^a   Youker, Keith A ^a   Grigore, Alina ^a   Clubb, Fred ^a   Radovancevic, Branislav ^a   Frazier, O Howard ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CELL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE REMOVAL; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GEL MOBILITY SHIFT ASSAY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART WORK; HUMAN; HUMAN TISSUE; IMPLANTATION; ISCHEMIC HEART DISEASE; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 20144385456     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.02.003     Document Type: Article

References (39)

1. Purcell N.H., Molkentin J.D. Is nuclear factor κB an attractive therapeutic target for treating cardiac hypertrophy? Circulation. 108:2003;638-640
2. Calderone A. The therapeutic effect of natriuretic peptides in heart failure Differential regulation of endothelial and inducible nitric oxide synthases. Heart Fail Rev. 8:2003;55-70
3. Valin G., Yan Z.Q., Hansson G.K. Nuclear factor kappa-B and the heart. J Am Coll Cardiol. 38:2001;307-314
4. Wu A.H.B. Cardiac markers. 2nd ed :2003;Humana Press, Totowa, NJ
5. Aukrust P., Ueland T., Lien E., et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 83:1999;376-382
6. Birks E.J., Latif N., Owen V., et al. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation. 104:1997;233-240
7. Ferrari R. Tumor necrosis factor in CHF A double facet cytokine. Cardiovasc Res. 37:1998;554-559
8. Drexler H., Kastner S., Strobel A., Struder R., Brodde O.E., Hasenfuss G. Expression, activity and functional significance of inducible nitric oxide in the failing human heart. J Am Coll Cardiol. 32:1998;955-963
9. Habib F.M., Springall D.R., Davies G.J., Oakley C.M., Yacoub Y.M., Polak J.M. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155
10. Haywood G.A., Tsao P.S., von der Leyden H.E., et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094
11. Mustapha S., Skirshner A., De Moissac D., Kirshenbaum L.A. A direct requirement of nuclear factor-κB for suppression of apoptosis in ventricular myocytes. Am J Physiol (Heart Circ). 279:2000;H939-H945
12. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141
13. Nutt L., Bick R., Buja L.M. IL-1 beta protects against hypoxia induced nuclear calcium overload and TNF protects against chemically induced nuclear calcium overload in neonatal rat cardiac myocytes. FASEB J (Baltimore). 7:1996;A128
14. Razeghi P., Mukhopadhyay M., Myers T.J., et al. Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg. 72:2001;2044-2050
15. Shames B.D., Barton H.H., Reznikov L.L., et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock. 17:2002;114-119
16. Vejlstrup N.G., Bouloumie A., Boesgaard S., et al. Inducible nitric oxide synthase (iNOS) in the human heart Expression and localization in congestive heart failure. J Mol Cell Cardiol. 30:1998;1215-1223
17. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res. 53:2002;31-47
18. Morishita R., Sugimoto T., Aoki M., et al. In vivo transfection of cis element "decoy" against nuclear transcription factor-kappaB binding site prevents myocardial infarction. Nat Med. 3:1997;834-835
19. Bick R.J., Liao J.P., King T.W., LeMaistre A., McMillin J.B., Buja L.M. Temporal effects of cytokines on neonatal cardiac myocyte calcium transients and adenylate cyclase activity. Am J Physiol. 272:1997;H1937-H1944
20. Bick R.J., Wood D.E., Poindexter B.J., et al. Cytokines increase neonatal cardiac myocyte calcium concentrations. The involvement of nitric oxide and cyclic nucleotides. J Interfer Cytok Res. 19:1999;645-653
21. Wang D., McMillin J.B., Bick R.J., Buja L.M. Response of the neonatal rat cardiomyocyte in culture to energy depletion Effects of cytokines, nitric oxide and heat shock proteins. Lab Invest. 75:1996;809-818
22. Le Corvoisier P., Lopes M.E., Su J., Hittinger L. Role of nitric oxide in heart failure. J Soc Biol. 194:2000;143-149
23. Gealekman O., Abassi Z., Rubinstein I., Winaver J., Binah O. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation. 105:2002;236-243
24. Ziolo M.T., Katoh H., Bers D.M. Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from sarcoplasmic reticulum in intact ventricular myocytes. Circulation. 104:2001;2961-2966
25. Yoshimura M., Yasue H., Morita E., et al. Hemodynamic, renal and hormonal responses to brain natriuretic peptide in fusion in patients with congestive heart failure. Circulation. 84:1991;1581-1588
26. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 93:1996;1963-1969
27. Bick R.J., Poindexter B.J., Buja L.M., et al. Improved sarcoplasmic reticulum function after mechanical left ventricular unloading. J Cardiovasc Pathobiol. 2:1998;159-166
28. Hehnke-Vagnoni K.E., Clark C.L., Taylor M.J., Ford S.P. Presence and localization of tumor necrosis factor in the corpus luteum of nonpregnant and pregnant pigs. Biol Reprod. 53:1995;1339-1344
29. Abdo M., Hisheh S., Dhamarajan A. Role of tumor necrosis factor-alpha and the modulating effect of the caspases in rat corpus luteum apoptosis. Biol Reprod. 68:2003;1241-1248
30. Muller M.M., Schrelber E., Schaffner W., Matthlas P. Rapid test for in vivo stability and DNA binding for mutated octamer binding proteins with 'mini-extracts' prepared from transfected cells. Nucl Acids Res. 17:1989;6420
31. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines mediated by nitric oxide. Science. 257:1992;387-389
32. Kelly R.A., Smith T.W. Cytokines and cardiac contractile function. Circulation. 95:1997;778-781
33. Wada H., Saito K., Kanda T., et al. Tumor necrosis factor-α (TNF-α) plays a protective role in acute viral myocarditis in mice. Circulation. 103:2001;743-751
34. Yokoyama T., Vaca L., Rossen R.D., Durante W., Hazarika P., Mann D.L. Cellular basis for the negative inotropic effects of tumor necrosis-alpha in the adult mammalian heart. J Clin Invest. 92:1993;2303-2312
35. Kupatt C., Habazettl H., Goedecke A., et al. Tumor necrosis factor-alpha contributes to ischemia and reperfusion-induced endothelial activation in isolated hearts. Circ Res. 4:1999;392-400
36. Chandrasekar B., Freeman G.L. Induction of nuclear factor kappaB and activation protein 1 in post ischemic myocardium. FEBS Lett. 1:1997;30-34
37. Frazier O.H., Benedict C.R., Radovancevic B., et al. Improved left ventricular function after left ventricular unloading. Ann Thorac Surg. 62:1996;675-682
38. de Jonge N., van Wichen D.F., van Kuik J., et al. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device Low incidence of apoptosis despite ubiquitous mediators. Heart Lung Transplant. 22:2003;1028-1036
39. Jibiki T., Terai M., Tateno S., et al. Expression of tumor necrosis factor-α protein in myocardium in fatal myocarditis. Pediatr Int. 42:2000;43-47